Acute Respiratory Distress Syndrome due to Mycoplasma pneumoniae Misinterpreted as SARS-CoV-2 Infection

Table 1

Patient characteristics and laboratory parameters at various time points during infection with M. pneumoniae.

Parameter
Gender	Male
Age (years)	36
Height (cm)	190
Weight (kg)	90
Body mass index (kg/m^2)	24.9
Antimicrobial therapy (therapy started on the 14^th of March, the patient transferred on the 22^nd of March)
Piperacillin/tazobactam	14.03-18.03
Meropenem	18.03-24.03
Linezolid	17.03-22.03
Fosfomycin	17.03-22.03
Clarithromycin	14.03-16.03 and 22.03–03.04
Laboratory findings	Date
	22^nd of March	2^nd of April	6^th of April	Normal values
LDH (IU/L)	993	532	512	0–262
CRP (mg/L)	216	13	4.8	0.0-5.0
Bilirubin (mg/dL)	1.4	0.5	0.4	<1.2
Haptoglobin	<5	n.a.	n.a.	>5
Creatinine (mg/dL)	1.03	0.68	0.76	0.70–1.20
Sodium (mmol/L)	148	140	141	135–145
Potassium (mmol/L)	5.4	4.2	5.6	3.5–5.1
Hemoglobin (g/dL)	5.3	7.7	9.0	14.0–18.0
WBC (G/L)	16.8	6.6	7.6	3.9–10.2
Thrombocytes (T/μL)	351	559	568	140–400
Fibrinogen (g/L)	354	369	420	180–400
Interleukin 6 (pg/mL)	51.5	n.a.	n.a.	<7
D-dimers (mg/L)	12.6	n.a.	n.a.	<0.50

n.a.: not available.